nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCB1—ovarian cancer	0.279	1	CbGaD
Amprenavir—ABCC1—Epirubicin—ovarian cancer	0.0796	0.137	CbGbCtD
Amprenavir—ABCC1—Paclitaxel—ovarian cancer	0.0785	0.135	CbGbCtD
Amprenavir—ABCC1—Docetaxel—ovarian cancer	0.0568	0.0974	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—ovarian cancer	0.0423	0.0726	CbGbCtD
Amprenavir—ABCB1—Topotecan—ovarian cancer	0.0383	0.0657	CbGbCtD
Amprenavir—CYP3A5—Paclitaxel—ovarian cancer	0.0291	0.05	CbGbCtD
Amprenavir—CYP2C8—Paclitaxel—ovarian cancer	0.028	0.048	CbGbCtD
Amprenavir—ABCB1—Vinorelbine—ovarian cancer	0.027	0.0463	CbGbCtD
Amprenavir—CYP2D6—Vinorelbine—ovarian cancer	0.0254	0.0436	CbGbCtD
Amprenavir—CYP3A4—Topotecan—ovarian cancer	0.0229	0.0394	CbGbCtD
Amprenavir—CYP3A5—Docetaxel—ovarian cancer	0.0211	0.0361	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—ovarian cancer	0.0199	0.0342	CbGbCtD
Amprenavir—CYP2C9—Paclitaxel—ovarian cancer	0.0195	0.0335	CbGbCtD
Amprenavir—ABCB1—Paclitaxel—ovarian cancer	0.019	0.0325	CbGbCtD
Amprenavir—CYP3A4—Vinorelbine—ovarian cancer	0.0162	0.0277	CbGbCtD
Amprenavir—ABCB1—Docetaxel—ovarian cancer	0.0137	0.0235	CbGbCtD
Amprenavir—CYP3A4—Paclitaxel—ovarian cancer	0.0114	0.0195	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—ovarian cancer	0.0102	0.0175	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—ovarian cancer	0.00962	0.0165	CbGbCtD
Amprenavir—CYP3A4—Docetaxel—ovarian cancer	0.00821	0.0141	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—ovarian cancer	0.00612	0.0105	CbGbCtD
Amprenavir—Asthenia—Altretamine—ovarian cancer	0.00106	0.00773	CcSEcCtD
Amprenavir—Opportunistic infection—Doxorubicin—ovarian cancer	0.000988	0.00722	CcSEcCtD
Amprenavir—Vomiting—Altretamine—ovarian cancer	0.000938	0.00685	CcSEcCtD
Amprenavir—Myositis—Epirubicin—ovarian cancer	0.000877	0.00641	CcSEcCtD
Amprenavir—Nausea—Altretamine—ovarian cancer	0.000876	0.0064	CcSEcCtD
Amprenavir—Neutropenia—Chlorambucil—ovarian cancer	0.000862	0.0063	CcSEcCtD
Amprenavir—Liver function test abnormal—Melphalan—ovarian cancer	0.000858	0.00627	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Topotecan—ovarian cancer	0.000855	0.00625	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Topotecan—ovarian cancer	0.000837	0.00612	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Paclitaxel—ovarian cancer	0.000827	0.00605	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.000815	0.00595	CcSEcCtD
Amprenavir—Myositis—Doxorubicin—ovarian cancer	0.000812	0.00593	CcSEcCtD
Amprenavir—Neutropenia—Topotecan—ovarian cancer	0.000767	0.00561	CcSEcCtD
Amprenavir—Neutropenia—Melphalan—ovarian cancer	0.000751	0.00549	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Vinorelbine—ovarian cancer	0.000731	0.00535	CcSEcCtD
Amprenavir—Transaminases increased—Epirubicin—ovarian cancer	0.000707	0.00517	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Docetaxel—ovarian cancer	0.000701	0.00513	CcSEcCtD
Amprenavir—Erythema multiforme—Chlorambucil—ovarian cancer	0.000697	0.0051	CcSEcCtD
Amprenavir—Hepatobiliary disease—Topotecan—ovarian cancer	0.000692	0.00506	CcSEcCtD
Amprenavir—Hepatobiliary disease—Melphalan—ovarian cancer	0.000677	0.00495	CcSEcCtD
Amprenavir—Inflammation—Docetaxel—ovarian cancer	0.000657	0.00481	CcSEcCtD
Amprenavir—Neutropenia—Vinorelbine—ovarian cancer	0.000656	0.0048	CcSEcCtD
Amprenavir—Transaminases increased—Doxorubicin—ovarian cancer	0.000654	0.00478	CcSEcCtD
Amprenavir—Connective tissue disorder—Melphalan—ovarian cancer	0.000632	0.00462	CcSEcCtD
Amprenavir—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.000617	0.00451	CcSEcCtD
Amprenavir—Myocardial infarction—Vinorelbine—ovarian cancer	0.000613	0.00448	CcSEcCtD
Amprenavir—Tremor—Chlorambucil—ovarian cancer	0.000602	0.0044	CcSEcCtD
Amprenavir—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.000592	0.00433	CcSEcCtD
Amprenavir—Angioedema—Chlorambucil—ovarian cancer	0.000587	0.00429	CcSEcCtD
Amprenavir—Malnutrition—Topotecan—ovarian cancer	0.000572	0.00418	CcSEcCtD
Amprenavir—Connective tissue disorder—Vinorelbine—ovarian cancer	0.000552	0.00404	CcSEcCtD
Amprenavir—Angioedema—Topotecan—ovarian cancer	0.000522	0.00382	CcSEcCtD
Amprenavir—Cardiac disorder—Vinorelbine—ovarian cancer	0.000521	0.00381	CcSEcCtD
Amprenavir—Liver function test abnormal—Paclitaxel—ovarian cancer	0.000504	0.00369	CcSEcCtD
Amprenavir—Anorexia—Chlorambucil—ovarian cancer	0.0005	0.00365	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Paclitaxel—ovarian cancer	0.000492	0.0036	CcSEcCtD
Amprenavir—Malnutrition—Vinorelbine—ovarian cancer	0.000489	0.00357	CcSEcCtD
Amprenavir—Myalgia—Topotecan—ovarian cancer	0.000487	0.00356	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000483	0.00353	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Paclitaxel—ovarian cancer	0.000482	0.00352	CcSEcCtD
Amprenavir—Discomfort—Topotecan—ovarian cancer	0.000481	0.00351	CcSEcCtD
Amprenavir—Myalgia—Melphalan—ovarian cancer	0.000477	0.00348	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000473	0.00346	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Epirubicin—ovarian cancer	0.000473	0.00346	CcSEcCtD
Amprenavir—Nervous system disorder—Topotecan—ovarian cancer	0.000458	0.00334	CcSEcCtD
Amprenavir—Decreased appetite—Chlorambucil—ovarian cancer	0.000456	0.00333	CcSEcCtD
Amprenavir—Skin disorder—Topotecan—ovarian cancer	0.000453	0.00331	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000452	0.00331	CcSEcCtD
Amprenavir—Fatigue—Chlorambucil—ovarian cancer	0.000452	0.0033	CcSEcCtD
Amprenavir—Angioedema—Vinorelbine—ovarian cancer	0.000447	0.00327	CcSEcCtD
Amprenavir—Anorexia—Topotecan—ovarian cancer	0.000445	0.00325	CcSEcCtD
Amprenavir—Skin disorder—Melphalan—ovarian cancer	0.000444	0.00324	CcSEcCtD
Amprenavir—Inflammation—Epirubicin—ovarian cancer	0.000443	0.00324	CcSEcCtD
Amprenavir—Neutropenia—Paclitaxel—ovarian cancer	0.000441	0.00323	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—ovarian cancer	0.000438	0.0032	CcSEcCtD
Amprenavir—Anorexia—Melphalan—ovarian cancer	0.000435	0.00318	CcSEcCtD
Amprenavir—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.000429	0.00313	CcSEcCtD
Amprenavir—Liver function test abnormal—Docetaxel—ovarian cancer	0.000427	0.00312	CcSEcCtD
Amprenavir—Hyperglycaemia—Paclitaxel—ovarian cancer	0.000426	0.00311	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000425	0.00311	CcSEcCtD
Amprenavir—Depression—Paclitaxel—ovarian cancer	0.00042	0.00307	CcSEcCtD
Amprenavir—Paraesthesia—Topotecan—ovarian cancer	0.000419	0.00306	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.000417	0.00305	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Docetaxel—ovarian cancer	0.000417	0.00305	CcSEcCtD
Amprenavir—Myalgia—Vinorelbine—ovarian cancer	0.000416	0.00304	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000416	0.00304	CcSEcCtD
Amprenavir—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.000415	0.00303	CcSEcCtD
Amprenavir—Abdominal pain—Chlorambucil—ovarian cancer	0.000414	0.00303	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000413	0.00302	CcSEcCtD
Amprenavir—Myocardial infarction—Paclitaxel—ovarian cancer	0.000413	0.00302	CcSEcCtD
Amprenavir—Discomfort—Vinorelbine—ovarian cancer	0.000411	0.00301	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—ovarian cancer	0.00041	0.003	CcSEcCtD
Amprenavir—Paraesthesia—Melphalan—ovarian cancer	0.00041	0.003	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Docetaxel—ovarian cancer	0.000408	0.00298	CcSEcCtD
Amprenavir—Decreased appetite—Topotecan—ovarian cancer	0.000406	0.00296	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000403	0.00294	CcSEcCtD
Amprenavir—Fatigue—Topotecan—ovarian cancer	0.000402	0.00294	CcSEcCtD
Amprenavir—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000398	0.00291	CcSEcCtD
Amprenavir—Decreased appetite—Melphalan—ovarian cancer	0.000397	0.0029	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000394	0.00288	CcSEcCtD
Amprenavir—Fatigue—Melphalan—ovarian cancer	0.000394	0.00288	CcSEcCtD
Amprenavir—Nervous system disorder—Vinorelbine—ovarian cancer	0.000391	0.00286	CcSEcCtD
Amprenavir—Skin disorder—Vinorelbine—ovarian cancer	0.000388	0.00283	CcSEcCtD
Amprenavir—Gastrointestinal pain—Topotecan—ovarian cancer	0.000381	0.00279	CcSEcCtD
Amprenavir—Anorexia—Vinorelbine—ovarian cancer	0.00038	0.00278	CcSEcCtD
Amprenavir—Asthenia—Chlorambucil—ovarian cancer	0.000376	0.00275	CcSEcCtD
Amprenavir—Neutropenia—Docetaxel—ovarian cancer	0.000374	0.00273	CcSEcCtD
Amprenavir—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000371	0.00271	CcSEcCtD
Amprenavir—Pruritus—Chlorambucil—ovarian cancer	0.000371	0.00271	CcSEcCtD
Amprenavir—Abdominal pain—Topotecan—ovarian cancer	0.000369	0.0027	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000364	0.00266	CcSEcCtD
Amprenavir—Diabetes mellitus—Epirubicin—ovarian cancer	0.000359	0.00262	CcSEcCtD
Amprenavir—Diarrhoea—Chlorambucil—ovarian cancer	0.000359	0.00262	CcSEcCtD
Amprenavir—Paraesthesia—Vinorelbine—ovarian cancer	0.000358	0.00262	CcSEcCtD
Amprenavir—Erythema multiforme—Paclitaxel—ovarian cancer	0.000357	0.00261	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000354	0.00259	CcSEcCtD
Amprenavir—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000352	0.00257	CcSEcCtD
Amprenavir—Cardiac disorder—Paclitaxel—ovarian cancer	0.000351	0.00256	CcSEcCtD
Amprenavir—Myocardial infarction—Docetaxel—ovarian cancer	0.00035	0.00256	CcSEcCtD
Amprenavir—Decreased appetite—Vinorelbine—ovarian cancer	0.000347	0.00254	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000345	0.00252	CcSEcCtD
Amprenavir—Fatigue—Vinorelbine—ovarian cancer	0.000344	0.00252	CcSEcCtD
Amprenavir—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000337	0.00247	CcSEcCtD
Amprenavir—Asthenia—Topotecan—ovarian cancer	0.000335	0.00245	CcSEcCtD
Amprenavir—Vomiting—Chlorambucil—ovarian cancer	0.000333	0.00244	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000332	0.00243	CcSEcCtD
Amprenavir—Mental disorder—Paclitaxel—ovarian cancer	0.000331	0.00242	CcSEcCtD
Amprenavir—Pruritus—Topotecan—ovarian cancer	0.00033	0.00241	CcSEcCtD
Amprenavir—Malnutrition—Paclitaxel—ovarian cancer	0.000329	0.0024	CcSEcCtD
Amprenavir—Asthenia—Melphalan—ovarian cancer	0.000328	0.0024	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000326	0.00239	CcSEcCtD
Amprenavir—Flatulence—Paclitaxel—ovarian cancer	0.000324	0.00237	CcSEcCtD
Amprenavir—Pruritus—Melphalan—ovarian cancer	0.000323	0.00236	CcSEcCtD
Amprenavir—Diarrhoea—Topotecan—ovarian cancer	0.000319	0.00233	CcSEcCtD
Amprenavir—Abdominal pain—Vinorelbine—ovarian cancer	0.000315	0.00231	CcSEcCtD
Amprenavir—Connective tissue disorder—Docetaxel—ovarian cancer	0.000315	0.0023	CcSEcCtD
Amprenavir—Diarrhoea—Melphalan—ovarian cancer	0.000313	0.00228	CcSEcCtD
Amprenavir—Nausea—Chlorambucil—ovarian cancer	0.000311	0.00228	CcSEcCtD
Amprenavir—Tremor—Paclitaxel—ovarian cancer	0.000308	0.00225	CcSEcCtD
Amprenavir—Erythema multiforme—Docetaxel—ovarian cancer	0.000303	0.00221	CcSEcCtD
Amprenavir—Angioedema—Paclitaxel—ovarian cancer	0.000301	0.0022	CcSEcCtD
Amprenavir—Cardiac disorder—Docetaxel—ovarian cancer	0.000297	0.00217	CcSEcCtD
Amprenavir—Vomiting—Topotecan—ovarian cancer	0.000297	0.00217	CcSEcCtD
Amprenavir—Rash—Topotecan—ovarian cancer	0.000294	0.00215	CcSEcCtD
Amprenavir—Dermatitis—Topotecan—ovarian cancer	0.000294	0.00215	CcSEcCtD
Amprenavir—Headache—Topotecan—ovarian cancer	0.000292	0.00214	CcSEcCtD
Amprenavir—Vomiting—Melphalan—ovarian cancer	0.00029	0.00212	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—ovarian cancer	0.000288	0.00211	CcSEcCtD
Amprenavir—Rash—Melphalan—ovarian cancer	0.000288	0.00211	CcSEcCtD
Amprenavir—Dermatitis—Melphalan—ovarian cancer	0.000288	0.0021	CcSEcCtD
Amprenavir—Asthenia—Vinorelbine—ovarian cancer	0.000286	0.00209	CcSEcCtD
Amprenavir—Pruritus—Vinorelbine—ovarian cancer	0.000282	0.00206	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000281	0.00206	CcSEcCtD
Amprenavir—Mental disorder—Docetaxel—ovarian cancer	0.000281	0.00205	CcSEcCtD
Amprenavir—Myalgia—Paclitaxel—ovarian cancer	0.00028	0.00205	CcSEcCtD
Amprenavir—Malnutrition—Docetaxel—ovarian cancer	0.000279	0.00204	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000278	0.00203	CcSEcCtD
Amprenavir—Nausea—Topotecan—ovarian cancer	0.000277	0.00203	CcSEcCtD
Amprenavir—Discomfort—Paclitaxel—ovarian cancer	0.000277	0.00202	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000275	0.00201	CcSEcCtD
Amprenavir—Diarrhoea—Vinorelbine—ovarian cancer	0.000273	0.002	CcSEcCtD
Amprenavir—Nausea—Melphalan—ovarian cancer	0.000271	0.00198	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000267	0.00195	CcSEcCtD
Amprenavir—Nervous system disorder—Paclitaxel—ovarian cancer	0.000263	0.00192	CcSEcCtD
Amprenavir—Skin disorder—Paclitaxel—ovarian cancer	0.000261	0.00191	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00026	0.0019	CcSEcCtD
Amprenavir—Anorexia—Paclitaxel—ovarian cancer	0.000256	0.00187	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000255	0.00186	CcSEcCtD
Amprenavir—Vomiting—Vinorelbine—ovarian cancer	0.000254	0.00185	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—ovarian cancer	0.000252	0.00184	CcSEcCtD
Amprenavir—Rash—Vinorelbine—ovarian cancer	0.000252	0.00184	CcSEcCtD
Amprenavir—Dermatitis—Vinorelbine—ovarian cancer	0.000251	0.00184	CcSEcCtD
Amprenavir—Headache—Vinorelbine—ovarian cancer	0.00025	0.00183	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000245	0.00179	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—ovarian cancer	0.000243	0.00178	CcSEcCtD
Amprenavir—Paraesthesia—Paclitaxel—ovarian cancer	0.000241	0.00176	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000239	0.00174	CcSEcCtD
Amprenavir—Myalgia—Docetaxel—ovarian cancer	0.000237	0.00174	CcSEcCtD
Amprenavir—Nausea—Vinorelbine—ovarian cancer	0.000237	0.00173	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000236	0.00172	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—ovarian cancer	0.000233	0.00171	CcSEcCtD
Amprenavir—Decreased appetite—Paclitaxel—ovarian cancer	0.000233	0.00171	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000232	0.00169	CcSEcCtD
Amprenavir—Fatigue—Paclitaxel—ovarian cancer	0.000231	0.00169	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000228	0.00166	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000225	0.00165	CcSEcCtD
Amprenavir—Nervous system disorder—Docetaxel—ovarian cancer	0.000223	0.00163	CcSEcCtD
Amprenavir—Skin disorder—Docetaxel—ovarian cancer	0.000221	0.00162	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000221	0.00161	CcSEcCtD
Amprenavir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00022	0.0016	CcSEcCtD
Amprenavir—Anorexia—Docetaxel—ovarian cancer	0.000217	0.00159	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—ovarian cancer	0.000212	0.00155	CcSEcCtD
Amprenavir—Abdominal pain—Paclitaxel—ovarian cancer	0.000212	0.00155	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000211	0.00154	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000207	0.00152	CcSEcCtD
Amprenavir—Paraesthesia—Docetaxel—ovarian cancer	0.000204	0.00149	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—ovarian cancer	0.000204	0.00149	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—ovarian cancer	0.0002	0.00147	CcSEcCtD
Amprenavir—Decreased appetite—Docetaxel—ovarian cancer	0.000198	0.00145	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000196	0.00144	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000196	0.00144	CcSEcCtD
Amprenavir—Fatigue—Docetaxel—ovarian cancer	0.000196	0.00143	CcSEcCtD
Amprenavir—Asthenia—Paclitaxel—ovarian cancer	0.000193	0.00141	CcSEcCtD
Amprenavir—Pruritus—Paclitaxel—ovarian cancer	0.00019	0.00139	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—ovarian cancer	0.000189	0.00138	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—ovarian cancer	0.000189	0.00138	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—ovarian cancer	0.000188	0.00137	CcSEcCtD
Amprenavir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000186	0.00136	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—ovarian cancer	0.000185	0.00136	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—ovarian cancer	0.000185	0.00135	CcSEcCtD
Amprenavir—Diarrhoea—Paclitaxel—ovarian cancer	0.000184	0.00134	CcSEcCtD
Amprenavir—Abdominal pain—Docetaxel—ovarian cancer	0.00018	0.00131	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—ovarian cancer	0.000175	0.00128	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—ovarian cancer	0.000174	0.00127	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—ovarian cancer	0.000171	0.00125	CcSEcCtD
Amprenavir—Vomiting—Paclitaxel—ovarian cancer	0.000171	0.00125	CcSEcCtD
Amprenavir—Rash—Paclitaxel—ovarian cancer	0.000169	0.00124	CcSEcCtD
Amprenavir—Dermatitis—Paclitaxel—ovarian cancer	0.000169	0.00124	CcSEcCtD
Amprenavir—Headache—Paclitaxel—ovarian cancer	0.000168	0.00123	CcSEcCtD
Amprenavir—Asthenia—Docetaxel—ovarian cancer	0.000163	0.00119	CcSEcCtD
Amprenavir—Pruritus—Docetaxel—ovarian cancer	0.000161	0.00118	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—ovarian cancer	0.00016	0.00117	CcSEcCtD
Amprenavir—Nausea—Paclitaxel—ovarian cancer	0.000159	0.00117	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000159	0.00116	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—ovarian cancer	0.000158	0.00116	CcSEcCtD
Amprenavir—Diarrhoea—Docetaxel—ovarian cancer	0.000156	0.00114	CcSEcCtD
Amprenavir—Nervous system disorder—Epirubicin—ovarian cancer	0.00015	0.0011	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—ovarian cancer	0.000149	0.00109	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—ovarian cancer	0.000148	0.00108	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000147	0.00108	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—ovarian cancer	0.000146	0.00107	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—ovarian cancer	0.000146	0.00107	CcSEcCtD
Amprenavir—Vomiting—Docetaxel—ovarian cancer	0.000145	0.00106	CcSEcCtD
Amprenavir—Rash—Docetaxel—ovarian cancer	0.000143	0.00105	CcSEcCtD
Amprenavir—Dermatitis—Docetaxel—ovarian cancer	0.000143	0.00105	CcSEcCtD
Amprenavir—Headache—Docetaxel—ovarian cancer	0.000143	0.00104	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00014	0.00102	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—ovarian cancer	0.000139	0.00102	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—ovarian cancer	0.000138	0.00101	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—ovarian cancer	0.000138	0.00101	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—ovarian cancer	0.000135	0.000989	CcSEcCtD
Amprenavir—Nausea—Docetaxel—ovarian cancer	0.000135	0.000988	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—ovarian cancer	0.000133	0.000975	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000132	0.000969	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—ovarian cancer	0.000132	0.000967	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000129	0.000946	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—ovarian cancer	0.000128	0.000932	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000125	0.000917	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—ovarian cancer	0.000123	0.000902	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000123	0.000896	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—ovarian cancer	0.000122	0.000895	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—ovarian cancer	0.000121	0.000887	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000116	0.000849	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—ovarian cancer	0.000112	0.000821	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—ovarian cancer	0.00011	0.000805	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—ovarian cancer	0.000109	0.000794	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—ovarian cancer	0.000105	0.000768	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—ovarian cancer	0.000102	0.000745	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—ovarian cancer	0.0001	0.000734	CcSEcCtD
Amprenavir—ABCC1—myometrium—ovarian cancer	9.89e-05	0.0596	CbGeAlD
Amprenavir—Vomiting—Epirubicin—ovarian cancer	9.76e-05	0.000713	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—ovarian cancer	9.72e-05	0.00071	CcSEcCtD
Amprenavir—Rash—Epirubicin—ovarian cancer	9.68e-05	0.000707	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—ovarian cancer	9.67e-05	0.000707	CcSEcCtD
Amprenavir—Headache—Epirubicin—ovarian cancer	9.61e-05	0.000703	CcSEcCtD
Amprenavir—Nausea—Epirubicin—ovarian cancer	9.12e-05	0.000666	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—ovarian cancer	9.03e-05	0.00066	CcSEcCtD
Amprenavir—Rash—Doxorubicin—ovarian cancer	8.95e-05	0.000654	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—ovarian cancer	8.94e-05	0.000654	CcSEcCtD
Amprenavir—Headache—Doxorubicin—ovarian cancer	8.9e-05	0.00065	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—ovarian cancer	8.43e-05	0.000617	CcSEcCtD
Amprenavir—ABCC1—uterine cervix—ovarian cancer	7.7e-05	0.0464	CbGeAlD
Amprenavir—ABCC1—decidua—ovarian cancer	7.33e-05	0.0442	CbGeAlD
Amprenavir—ABCC1—endometrium—ovarian cancer	6.96e-05	0.0419	CbGeAlD
Amprenavir—ABCC1—uterus—ovarian cancer	6.41e-05	0.0386	CbGeAlD
Amprenavir—CYP2C8—endometrium—ovarian cancer	5.93e-05	0.0357	CbGeAlD
Amprenavir—CYP3A5—uterine cervix—ovarian cancer	5.91e-05	0.0356	CbGeAlD
Amprenavir—ABCC1—female gonad—ovarian cancer	5.25e-05	0.0316	CbGeAlD
Amprenavir—ABCC1—vagina—ovarian cancer	5.22e-05	0.0314	CbGeAlD
Amprenavir—CYP2C19—vagina—ovarian cancer	5.09e-05	0.0307	CbGeAlD
Amprenavir—CYP2B6—gonad—ovarian cancer	4.93e-05	0.0297	CbGeAlD
Amprenavir—CYP2C8—female reproductive system—ovarian cancer	4.91e-05	0.0296	CbGeAlD
Amprenavir—ABCC1—testis—ovarian cancer	4.65e-05	0.028	CbGeAlD
Amprenavir—CYP2C8—vagina—ovarian cancer	4.44e-05	0.0268	CbGeAlD
Amprenavir—CYP2B6—female reproductive system—ovarian cancer	4.4e-05	0.0265	CbGeAlD
Amprenavir—CYP2C9—female reproductive system—ovarian cancer	4.36e-05	0.0263	CbGeAlD
Amprenavir—ABCB1—myometrium—ovarian cancer	4.04e-05	0.0243	CbGeAlD
Amprenavir—CYP3A5—female gonad—ovarian cancer	4.03e-05	0.0243	CbGeAlD
Amprenavir—CYP3A5—vagina—ovarian cancer	4.01e-05	0.0241	CbGeAlD
Amprenavir—CYP2B6—vagina—ovarian cancer	3.98e-05	0.024	CbGeAlD
Amprenavir—CYP2C8—testis—ovarian cancer	3.96e-05	0.0239	CbGeAlD
Amprenavir—ABCB1—embryo—ovarian cancer	3.88e-05	0.0234	CbGeAlD
Amprenavir—CYP2B6—testis—ovarian cancer	3.55e-05	0.0214	CbGeAlD
Amprenavir—ABCC1—lymph node—ovarian cancer	3.37e-05	0.0203	CbGeAlD
Amprenavir—CYP3A4—female reproductive system—ovarian cancer	3.33e-05	0.02	CbGeAlD
Amprenavir—CYP2D6—female reproductive system—ovarian cancer	3.27e-05	0.0197	CbGeAlD
Amprenavir—ABCB1—epithelium—ovarian cancer	3.17e-05	0.0191	CbGeAlD
Amprenavir—ABCB1—uterine cervix—ovarian cancer	3.14e-05	0.0189	CbGeAlD
Amprenavir—ABCB1—decidua—ovarian cancer	2.99e-05	0.018	CbGeAlD
Amprenavir—CYP2D6—female gonad—ovarian cancer	2.98e-05	0.0179	CbGeAlD
Amprenavir—ABCB1—endometrium—ovarian cancer	2.84e-05	0.0171	CbGeAlD
Amprenavir—CYP2D6—testis—ovarian cancer	2.64e-05	0.0159	CbGeAlD
Amprenavir—ABCB1—gonad—ovarian cancer	2.64e-05	0.0159	CbGeAlD
Amprenavir—ABCB1—uterus—ovarian cancer	2.62e-05	0.0158	CbGeAlD
Amprenavir—ABCB1—female reproductive system—ovarian cancer	2.35e-05	0.0142	CbGeAlD
Amprenavir—ABCB1—bone marrow—ovarian cancer	2.22e-05	0.0134	CbGeAlD
Amprenavir—ABCB1—female gonad—ovarian cancer	2.14e-05	0.0129	CbGeAlD
Amprenavir—ABCB1—vagina—ovarian cancer	2.13e-05	0.0128	CbGeAlD
Amprenavir—ABCB1—testis—ovarian cancer	1.9e-05	0.0114	CbGeAlD
Amprenavir—ABCB1—lymph node—ovarian cancer	1.38e-05	0.0083	CbGeAlD
